Deciphering the role of Enterococcus faecium cytidine deaminase in gemcitabine resistance of gallbladder cancer
Open Access
- 15 March 2024
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 300 (4) , 107171
Abstract
No abstract availableKeywords
Funding Information
- Salt Science Research Foundation
- National Natural Science Foundation of China (32130036, 32171186, 32201058)
This publication has 47 references indexed in Scilit:
- Association of Antibiotic Receipt With Survival Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma Receiving ChemotherapyJAMA Network Open, 2023
- A metagenomic study of biliary microbiome change along the cholecystitis‐carcinoma sequenceClinical and Translational Medicine, 2020
- Biochemical and structural analysis of the Klebsiella pneumoniae cytidine deaminase CDABiochemical and Biophysical Research Communications, 2019
- Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract CancersJAMA Oncology, 2019
- Cytosolic 5′-nucleotidase 1A is overexpressed in pancreatic cancer and mediates gemcitabine resistance by reducing intracellular gemcitabine metabolitesEBioMedicine, 2019
- Insights into gemcitabine resistance and the potential for therapeutic monitoringMetabolomics, 2018
- Gallbladder CancerJAMA, 2018
- Using the PyMOL application to reinforce visual understanding of protein structureBiochemistry and Molecular Biology Education, 2016
- Gemcitabine resistance in pancreatic ductal adenocarcinomaDrug Resistance Updates, 2015
- Cytidine Deaminase. The 2·3 Å Crystal Structure of an Enzyme: Transition-state Analog ComplexJournal of Molecular Biology, 1994